Ramaswamy's Roivant Inks $650M R&D Deal With This Tiny Diabetes Biotech Post author:Sam Post published:February 11, 2018 Post category:BioPharma With the deal in hand, Roivant has stepped into the world of metabolic diseases. Source: BioSpace You Might Also Like Amniox Medical Obtains Federal Supply Schedule Contract For NEOX And CLARIX Product Lines April 16, 2017 Array BioPharma Slaps $192M Lawsuit on AstraZeneca Over Cancer Drug Royalties February 1, 2018 Standardizing On Veeva Systems, Inc. Vault Enhances Regeneron???s Clinical And Regulatory Operations Processes June 18, 2017
Amniox Medical Obtains Federal Supply Schedule Contract For NEOX And CLARIX Product Lines April 16, 2017
Standardizing On Veeva Systems, Inc. Vault Enhances Regeneron???s Clinical And Regulatory Operations Processes June 18, 2017
